Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)

Ozkan, M.Cicin, I.Ozaslan, E.Benekli, M.Oksuzoglu, B.Kocer, M.Isikdogan, A.2024-04-242024-04-2420150959-80491879-0852https://doi.org/10.1016/S0959-8049(16)30707-9https://hdl.handle.net/11468/16335European Cancer Congress -- 2015 -- Vienna, AUSTRIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)Conference Object51S245S245WOS:00036188740111310.1016/S0959-8049(16)30707-9Q1